Home/Pipeline/Breezing Med Commercialization

Breezing Med Commercialization

Weight Management, Nutritional Assessment

CommercialActive

Key Facts

Indication
Weight Management, Nutritional Assessment
Phase
Commercial
Status
Active
Company

About Breezing

Breezing is a commercial-stage medical device company offering a novel, portable metabolic analyzer. Its FDA-cleared Breezing Med device provides gold-standard indirect calorimetry measurements for personalized weight management and nutritional assessment in clinical settings, with features enabling remote patient monitoring and insurance reimbursement. Founded in 2013 by a team including Mayo Clinic fellows, the company leverages its proprietary sensor technology to disrupt the traditional metabolic cart market with a lower-cost, user-friendly solution validated by leading institutions.

View full company profile

Therapeutic Areas